CVS Health stock slips 2.00% to EUR 74.05 premarket
Published on 11/19/2026 at 08:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for investors
- CVS Health reported third-quarter 2026 revenue of USD 108.40 billion and adjusted earnings per share of USD 2.09 on November 4.
- The company raised its full-year 2026 adjusted earnings-per-share outlook to at least USD 8.20 from a prior range of USD 7.90 to USD 8.10.
- CVS Health expects operating cash flow of at least USD 15.5 billion for 2026 and adjusted earnings per share of at least USD 8.65 in 2027.
- TipRanks lists February 17, 2027 as the next estimated earnings date.
CVS Health stock slipped in premarket trading on Thursday, November 19, as investors weighed the healthcare group's latest outlook and continuing pressure on its insurance business. CVS Health stock traded at 74.05 euros on Lang & Schwarz at 08:51 CET on Thursday, November 19, 2.00 percent below the Xetra close of Wednesday, November 18.
CVS Health combines health insurance through Aetna with pharmacy services, retail pharmacies and healthcare delivery businesses. The company reported its third-quarter 2026 results on November 4, when revenue reached USD 108.40 billion and adjusted earnings per share came to USD 2.09. TipRanks reported that the result exceeded the listed consensus estimate of USD 1.65 per share and that revenue topped the USD 104.72 billion estimate.
Higher earnings and cash-flow outlook
Management raised full-year 2026 adjusted earnings-per-share guidance to at least USD 8.20, up from a prior range of USD 7.90 to USD 8.10. The company also lifted its operating cash-flow outlook to at least USD 15.5 billion and expects total revenue of at least USD 420 billion. For 2027, CVS Health set an adjusted earnings-per-share floor of USD 8.65, while elevated medical-cost trends remain a central operating risk.
The company also plans to separate its healthcare solutions operations from CVS Pharmacy, with completion expected in the first half of 2028, subject to customary conditions. TipRanks said the planned separation, medical-cost trends and expected 2027 pressure from 340B and lower Caremark membership were key topics in the earnings discussion.
Healthcare shares are trading in the wider context of the S&P 500.
More TipRanks reporting on the November 4 results lists February 17, 2027 as the next estimated earnings date. More news and analyses on CVS Health stock.
